Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Lastly, iron content in cecal contents was not different between the groups but showed a trend of increased levels in both VSG groups (Fig. 3j).Plasma levels of a FGF23, b phosphate, c 25(OH) vitamin D, d erythropoietin, e hemoglobin and f ferritin. g Heart to body weight ratio. h H&E stain of liver sections, CV = central vein, PV = portal vein, Zones 1 to 3, scale bars 100 μm. i RNA expression of Dmt1, Dcytb, Hamp, Slc401a1 (Fpn) and Hif2α in duodenum. j Iron levels in cecal contents.

Source: Loss of intestinal FGF15 increases circulating fibroblast growth factor 23 (FGF23) and erythropoietin (EPO) levels after VSG. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Mice were singly-housed under a 12-h light/dark cycle in a facility maintained at 25 °C with 50 to 60% humidity for the duration of the studies.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice

Study design awaiting verification · Nature Communications · 2021

Original publication title

Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice

Nadejda Bozadjieva-Kramer; Jae Hoon Shin; Yikai Shao; Ruth Gutierrez-Aguilar; Ziru Li; Kristy M. Heppner; Samuel Chiang; Sara G. Vargo; Katrina Granger; Darleen A. Sandoval; Ormond A. MacDougald; Randy J. Seeley

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Bariatric surgeries such as the Vertical Sleeve Gastrectomy (VSG) are invasive but provide the most effective improvements in obesity and Type 2 diabetes. We hypothesized a potential role for the gut hormone Fibroblast-Growth Factor 15/19 which is increased after VSG and pharmacologically can improve energy homeostasis and glucose handling. We generated intestinal-specific FGF15 knockout (FGF15INT-KO) mice which were maintained on high-fat diet. FGF15INT-KO mice lost more weight after VSG as a result of increased lean tissue loss.

FGF15INT-KO mice also lost more bone density and bone marrow adipose tissue after VSG. The effect of VSG to improve glucose tolerance was also absent in FGF15INT-KO. VSG resulted in increased plasma bile acid levels but were considerably higher in VSG-FGF15INT-KO mice. These data point to an important role after VSG for intestinal FGF15 to protect the organism from deleterious effects of VSG potentially by limiting the increase in circulating bile acids.

The mechanisms that mediate the effects of weight loss surgeries such as vertical sleeve gastrectomy (VSG) are incompletely understood. Here the authors show that intestinal FGF15 is necessary to improve glucose tolerance and to prevent the loss of muscle and bone mass after VSG, potentially via protection against bile acid toxicity.

Authors’ abstract

Bariatric surgeries such as the Vertical Sleeve Gastrectomy (VSG) are invasive but provide the most effective improvements in obesity and Type 2 diabetes. We hypothesized a potential role for the gut hormone Fibroblast-Growth Factor 15/19 which is increased after VSG and pharmacologically can improve energy homeostasis and glucose handling. We generated intestinal-specific FGF15 knockout (FGF15INT-KO) mice which were maintained on high-fat diet. FGF15INT-KO mice lost more weight after VSG as a result of increased lean tissue loss.

FGF15INT-KO mice also lost more bone density and bone marrow adipose tissue after VSG. The effect of VSG to improve glucose tolerance was also absent in FGF15INT-KO. VSG resulted in increased plasma bile acid levels but were considerably higher in VSG-FGF15INT-KO mice. These data point to an important role after VSG for intestinal FGF15 to protect the organism from deleterious effects of VSG potentially by limiting the increase in circulating bile acids.

The mechanisms that mediate the effects of weight loss surgeries such as vertical sleeve gastrectomy (VSG) are incompletely understood. Here the authors show that intestinal FGF15 is necessary to improve glucose tolerance and to prevent the loss of muscle and bone mass after VSG, potentially via protection against bile acid toxicity.

Publication and source details

Original title: Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice

Nadejda Bozadjieva-Kramer; Jae Hoon Shin; Yikai Shao; Ruth Gutierrez-Aguilar; Ziru Li; Kristy M. Heppner; Samuel Chiang; Sara G. Vargo; Katrina Granger; Darleen A. Sandoval; Ormond A. MacDougald; Randy J. Seeley

Nature Communications · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.NIH Support to University of Michigan Animal Phenotyping Core (1U2CDK110678-01), University of Michigan Physiology Phenotyping Core (P30-AR069620), Adipose Tissue Core of the MNORC (P30 DK089503), Michigan Integrative Musculoskeletal Health Core Center (P30 AR069620) and University of Michigan In-Vivo Animal Core (IVAC) at University of Michigan, Ann Arbor. This work was supported by Novo Nordisk (RJS), NIH 5T32DK108740 (NBK), 5T32DK071212-12 (NBK), UL1TR002240 (NBK), DK020572 (MDRC), DK089503 (MNORC), DK107282 (DAS), DK121995 (DAS), RO1 DK62876 (OAM), R24 DK092759 (OAM), American Diabetes Association grant (1-19-IBS-252; DAS), China Scholarship Council grant (CSC#201606100218) to YS, and American Diabetes Association (1-18-PDF-087) to ZL.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T11:58:53.018867+00:00

DOI: 10.1038/s41467-021-24914-y · PMC8346483